Placebo Control and Blinding in Randomized Trials of Procedural Interventions: A Systematic Review and...

Area of Science:

• Medical Interventions
• Clinical Trial Design
• Evidence-Based Medicine

Background:

• Procedural interventions are rarely evaluated against placebos before clinical adoption.
• This lack of placebo control may overestimate the efficacy of accepted procedures.
• Investigating the impact of placebo arms in procedural intervention trials is crucial.

Purpose of the Study:

• To assess the importance of placebo control in trials of surgical and interventional procedures.
• To compare effect sizes between trials with and without placebo arms for the same interventions.

Main Methods:

• Systematic search of MEDLINE and Embase for placebo-controlled trials of procedural interventions.
• Paired comparison with randomized clinical trials lacking placebo control.
• Random-effects meta-regression to analyze the impact of placebo control on various endpoints.

Main Results:

• Unblinded trials (without placebo control) showed significantly larger effect sizes for exercise-related outcomes, quality of life, and health care professional-assessed endpoints.
• The placebo effect accounted for a substantial portion of the observed effect in unblinded trials for these endpoints (88.1%, 55.2%, and 61.3%, respectively).
• No significant differences were observed between blinded and unblinded trials for patient-reported outcomes, blood pressure, mortality, pain, or bleeding events.

Conclusions:

• The magnitude of the placebo effect in procedural intervention trials varies by endpoint.
• Placebo control significantly impacts trials assessing exercise-related outcomes, quality of life, and professional-assessed results.
• Consideration of placebo control in randomized clinical trials of procedural interventions is recommended based on endpoint relevance.